已收盤 09-19 16:00:00 美东时间
+11.380
+1.00%
作为一个具有高成长性、高壁垒的双高赛道,眼科行业一直以来被誉为资本市场的“黄金赛道”。 近年来,随着人口老龄化进程加快、生活方式变化、电子产品的普及等,眼部疾病...
09-19 17:16
盈利问题,如同达摩克利斯之剑般悬挂在每一家biotech的头顶。 放眼国内市场,所有的公司都在为此努力,开源节流、降本增效,甚至有的公司开展全员BD、砍管线、转...
09-19 10:23
纳斯达克100指数转跌,成分股Atlassian目前跌超4.1%,PANW和CTSH跌超2%,Grail、博通、艺电、Mercadolibre、Adobe、特许...
09-18 00:25
RBC Capital analyst Brian Abrahams reiterates Regeneron Pharmaceuticals (NASDAQ:REGN) with a Outperform and maintains $1282 price target.
09-17 22:14
中国创新药公式:实力+运气+天时+地利 作者:西北哽 人的一生有几次追赶全球第一的机会? 2015年,陈博选择离开君实。当时编号为JS-001的特瑞普利单抗已...
09-14 21:01
Sanofi has inked an exclusive licensing deal with RadioMedix and OranoMed on a radioligand treatment for the rare cancer progressive somatostatin-receptor expressing neuroendocrine tumors. The deal w...
09-12 21:23
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
09-12 19:10
Regeneron (NASDAQ:REGN) and Sanofi (NASDAQ:SNY) on Wednesday announced that a Phase 3 trial for their blockbuster asthma therapy Dupixent for a skin condition known as bullous pemphigoid succeeded, wh...
09-11 19:35
MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announces favorable interim survival benefit from its lead
09-10 18:02
03. 再生元制药在过去10个月中,强生医疗技术业务实现了积极的增长,尽管面临挑战,公司致力于在2022年至2027年间实现5%至7%的增长目标。去年,公司在创...
09-10 07:40